Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Na+ Channel Blocker (Class Ia) |
|
|
Term
|
Definition
| Non selective beta 1/2- blocker (class II) |
|
|
Term
|
Definition
| Selective beta-1 blocker (Class II) |
|
|
Term
|
Definition
| Non selective beta 1/2- blocker + alpha-1 blocker (class II) |
|
|
Term
|
Definition
| Non selective beta 1/2- blocker + alpha-1 blocker (class II) |
|
|
Term
|
Definition
| K+ Channel blocker (Class III) |
|
|
Term
|
Definition
| K+ Channel blocker (Class III) |
|
|
Term
|
Definition
| K+ Channel blocker (Class III) |
|
|
Term
|
Definition
| Phosphodiesterase Inhibitor |
|
|
Term
|
Definition
| Sensitizer, inhibits phosphodiesterase (at high dose) |
|
|
Term
|
Definition
| Binds and activates antithrombin III |
|
|
Term
| Low Molecular Weight Heparin (Enoxaparin) |
|
Definition
| Binds and activates antithrombin III |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Direct thrombin inhibitor |
|
|
Term
|
Definition
| Binds plasminogen, promotes conversion to plasmin |
|
|
Term
| Tissue Plasminogen activator |
|
Definition
| Binds plasminogen, promotes conversion to plasmin |
|
|
Term
|
Definition
| Binds plasminogen, promotes conversion to plasmin |
|
|
Term
|
Definition
| Irreversible Cox-1 inhibitor |
|
|
Term
|
Definition
| Irreversible ADP receptor inhibitor |
|
|
Term
|
Definition
| Glycoprotein IIa/IIIa inhibitor |
|
|
Term
|
Definition
| Stimulates bone marrow to make RBCs |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Angiotensin-converting enzyme inhibitor |
|
|
Term
|
Definition
| Angiotensin II receptor (AT1) antagonist (ARB) |
|
|
Term
|
Definition
| Non selective endothelin-1 receptor antagonist |
|
|
Term
|
Definition
| Selective endothelin-1 receptor antagonist |
|
|
Term
|
Definition
| Brain natriuretic peptide analog |
|
|
Term
|
Definition
| D1 agonist (low), beta1 agonist (mid), alpha1 agonist (high) |
|
|
Term
|
Definition
| Pre-synaptic alpha-2 receptor agonist |
|
|
Term
|
Definition
| Pre-synaptic alpha-2 receptor agonist |
|
|
Term
|
Definition
| Nonselective competitive alpha 1/2 blocker |
|
|
Term
|
Definition
| Selective competitive alpha 1/2 bladder |
|
|
Term
|
Definition
| Ca2+ channel blocker (CLass IV), mainly coronaries |
|
|
Term
|
Definition
| Ca2+ channel blocker (Class IV), coronaries + nodes |
|
|
Term
|
Definition
| Ca2+ channel blocker (Class IV), coronaries + nodes + contractility |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Activates vascular ATP-sensitive K+ channels |
|
|
Term
|
Definition
| Activates vascular ATP-sensitive K+ channels |
|
|
Term
|
Definition
| Na+ channel blocker (transcellular late Na+ channel) |
|
|
Term
|
Definition
| Nitric oxide donor (guanylyl cyclase activator) |
|
|
Term
|
Definition
| Nitric oxide donor (guanylyl cyclase activator) |
|
|
Term
|
Definition
| HMG-CoA Reductase inhibitor |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Cholesterol absorption inhibitor |
|
|
Term
|
Definition
| Nuclear PPAR-alpha agonist |
|
|
Term
|
Definition
|
|
Term
|
Definition
MOA: Unknown
Net Effect: Blocked synthesis of VLDL from the liver, lipolysis |
|
|
Term
| Hydrochlorathiazide (HCTZ) |
|
Definition
| NaCl transport inhibitor (early DCT) |
|
|
Term
|
Definition
| NaCl transport inhibitor (early DCT) - longer half-life |
|
|
Term
|
Definition
| Loop Na-K-2Cl- co-transporter inhibitor |
|
|
Term
|
Definition
| Na+ channel blocker (collecting duct) |
|
|
Term
|
Definition
| Aldosterone antagonist (collecting duct) |
|
|
Term
|
Definition
| Carbonic anhydrase inhibitor |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Hormonally active form of Vit D |
|
|
Term
|
Definition
| Analog of Vit D (Vit D agonist) |
|
|
Term
|
Definition
| Binds dietary phophate and prevents absorption |
|
|
Term
|
Definition
| Binds dietary phophate and prevents absorption |
|
|
Term
|
Definition
| Vasopressin receptor blocker |
|
|
Term
|
Definition
| Competitive inhibitor of transpeptidase (PCN) |
|
|
Term
|
Definition
| Binds bacterial ribosome subunt 30S (aminoglycoside) |
|
|
Term
|
Definition
| Antibody against human T-cells |
|
|
Term
| Mycophenolate mofetil (MMF) |
|
Definition
| Inosine mono-phosphate dehydro-genase inhibitor |
|
|
Term
|
Definition
| Calcineurin inhibitor, blocking IL2 |
|
|
Term
|
Definition
| Reduces IL2 production by T-cells |
|
|
Term
|
Definition
| Steroid - downreg of cells/cytokines; lipocortin-1 up |
|
|
Term
|
Definition
| Steroid - downreg of cells/cytokines; lipocortin-1 up |
|
|
Term
|
Definition
| Steroid - downreg of cells/cytokines; lipocortin-1 up |
|
|
Term
|
Definition
| Mast cell Cl- channel inhibitor |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Leukotriene receptor blocker |
|
|
Term
|
Definition
| Anti-IgE humanized monoclonal antibody |
|
|
Term
|
Definition
| binds histamine receptors |
|
|
Term
|
Definition
| Short-acting beta2-agonist |
|
|
Term
|
Definition
| Long-acting beta2-agonist |
|
|
Term
|
Definition
| Long-acting beta2-agonist |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Muscarinic ACh receptor blocker |
|
|
Term
|
Definition
| Muscarinic ACh receptor blocker |
|
|
Term
|
Definition
| Phosphodiesterase inhibitor, adenosine inhibitor |
|
|
Term
|
Definition
| EGFR tyrosine kinase inhibitor (ATP-binding site) |
|
|
Term
|
Definition
| EGFR tyrosine kinase inhibitor (ATP-binding site) |
|
|
Term
|
Definition
| EGFR tyrosine kinase inhibitor (ATP-binding site) |
|
|
Term
|
Definition
| Inhibition of fungal ergosterol synthesis |
|
|
Term
|
Definition
| Improvement of Cl- transport through CFTR channel |
|
|
Term
| Diphenhydramine, Chlorpheniramine, Promethazine, Dimenhydrinate, Hydroxyzine |
|
Definition
| Histamine1-receptor antagonist (1st gen) |
|
|
Term
| Cetirizine, Desloratine, Fexofenidine, Loratidine |
|
Definition
| Histamine1-receptor antagonist (2nd gen) |
|
|
